| Title |
Sustained therapeutic effects of oral miglustat (Zavesca, N‐butyldeoxynojirimycin, OGT 918) in type I Gaucher disease
|
|---|---|
| Published in |
Journal of Inherited Metabolic Disease, November 2004
|
| DOI | 10.1023/b:boli.0000045756.54006.17 |
| Pubmed ID | |
| Authors |
D. Elstein, C. Hollak, J. M. F. G. Aerts, S. van Weely, M. Maas, T. M. Cox, R. H. Lachmann, M. Hrebicek, F. M. Platt, T. D. Butters, R. A. Dwek, A. Zimran |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 3% |
| United Kingdom | 1 | 2% |
| Netherlands | 1 | 2% |
| Unknown | 62 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 14 | 21% |
| Researcher | 14 | 21% |
| Student > Master | 11 | 17% |
| Student > Bachelor | 6 | 9% |
| Other | 5 | 8% |
| Other | 10 | 15% |
| Unknown | 6 | 9% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 20 | 30% |
| Agricultural and Biological Sciences | 14 | 21% |
| Biochemistry, Genetics and Molecular Biology | 6 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 9% |
| Chemistry | 5 | 8% |
| Other | 8 | 12% |
| Unknown | 7 | 11% |